Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nipro ( (JP:8086) ) has provided an announcement.
Nipro Corporation has booked extraordinary income of 5.169 billion yen from a gain on step acquisition after increasing its equity stake in G2/Spryte Holdco, LLC on December 19, 2025, turning the entity into a consolidated subsidiary. The gain arose from remeasuring Nipro’s previously held interest at fair value, and the impact has been incorporated into its consolidated financial results for the nine months ended December 31, 2025.
Despite this windfall, Nipro is leaving its earnings forecast for the fiscal year ending March 31, 2026 unchanged, citing a conservative stance amid unstable financial markets and foreign exchange volatility. The decision signals caution to investors and other stakeholders, as the company prioritizes risk management over revising guidance on the back of one-off income, while committing to update the market should forecast revisions become necessary.
The most recent analyst rating on (JP:8086) stock is a Hold with a Yen1593.00 price target. To see the full list of analyst forecasts on Nipro stock, see the JP:8086 Stock Forecast page.
More about Nipro
Nipro Corporation is a Japan-based manufacturer in the medical devices and life-sciences sectors, listed on the Tokyo Stock Exchange Prime Market under securities code 8086. The company focuses on products and services for healthcare and related fields, positioning itself as a key player in global medical technology and equipment supply.
YTD Price Performance: -2.20%
Average Trading Volume: 488,769
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen235.6B
Learn more about 8086 stock on TipRanks’ Stock Analysis page.